Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer.

Published in: Journal of gynecologic oncology (2019)

This study shows few adverse events, and promising clinical efficacy when using nivolumab for ovarian cancer.

Keyphrases